214 related articles for article (PubMed ID: 22380362)
21. Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment.
Lorentini S; Amichetti M; Spiazzi L; Tonoli S; Magrini SM; Fellin F; Schwarz M
Strahlenther Onkol; 2012 Mar; 188(3):216-25. PubMed ID: 22318326
[TBL] [Abstract][Full Text] [Related]
22. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
Mock U; Bogner J; Georg D; Auberger T; Pötter R
Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
[TBL] [Abstract][Full Text] [Related]
23. Uncertainty reduction in intensity modulated proton therapy by inverse Monte Carlo treatment planning.
Morávek Z; Rickhey M; Hartmann M; Bogner L
Phys Med Biol; 2009 Aug; 54(15):4803-19. PubMed ID: 19622848
[TBL] [Abstract][Full Text] [Related]
24. Implication of spot position error on plan quality and patient safety in pencil-beam-scanning proton therapy.
Yu J; Beltran CJ; Herman MG
Med Phys; 2014 Aug; 41(8):081706. PubMed ID: 25086516
[TBL] [Abstract][Full Text] [Related]
25. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
[TBL] [Abstract][Full Text] [Related]
26. Impact of Spot Size and Beam-Shaping Devices on the Treatment Plan Quality for Pencil Beam Scanning Proton Therapy.
Moteabbed M; Yock TI; Depauw N; Madden TM; Kooy HM; Paganetti H
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):190-198. PubMed ID: 27084640
[TBL] [Abstract][Full Text] [Related]
27. Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes.
Cubillos-Mesías M; Baumann M; Troost EGC; Lohaus F; Löck S; Richter C; Stützer K
Radiat Oncol; 2017 Nov; 12(1):190. PubMed ID: 29183377
[TBL] [Abstract][Full Text] [Related]
28. Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates.
van de Water S; Safai S; Schippers JM; Weber DC; Lomax AJ
Acta Oncol; 2019 Oct; 58(10):1463-1469. PubMed ID: 31241377
[No Abstract] [Full Text] [Related]
29. A fourier analysis on the maximum acceptable grid size for discrete proton beam dose calculation.
Li HS; Romeijn HE; Dempsey JF
Med Phys; 2006 Sep; 33(9):3508-18. PubMed ID: 17022247
[TBL] [Abstract][Full Text] [Related]
30. Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison.
Fellin F; Azzeroni R; Maggio A; Lorentini S; Cozzarini C; Di Muzio N; Fiorino C; Calandrino R; Schwarz M
Radiother Oncol; 2013 May; 107(2):207-12. PubMed ID: 23541644
[TBL] [Abstract][Full Text] [Related]
31. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.
Munck Af Rosenschöld P; Engelholm S; Ohlhues L; Law I; Vogelius I; Engelholm SA
Acta Oncol; 2011 Aug; 50(6):777-83. PubMed ID: 21767174
[TBL] [Abstract][Full Text] [Related]
32. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
33. A new treatment planning approach accounting for prompt gamma range verification and interfractional anatomical changes.
Tian L; Landry G; Dedes G; Pinto M; Kamp F; Belka C; Parodi K
Phys Med Biol; 2020 Apr; 65(9):095005. PubMed ID: 32135530
[TBL] [Abstract][Full Text] [Related]
34. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
[TBL] [Abstract][Full Text] [Related]
35. Intensity modulated photon and proton therapy for the treatment of head and neck tumors.
Steneker M; Lomax A; Schneider U
Radiother Oncol; 2006 Aug; 80(2):263-7. PubMed ID: 16916557
[TBL] [Abstract][Full Text] [Related]
36. A GPU-accelerated and Monte Carlo-based intensity modulated proton therapy optimization system.
Ma J; Beltran C; Seum Wan Chan Tseung H; Herman MG
Med Phys; 2014 Dec; 41(12):121707. PubMed ID: 25471954
[TBL] [Abstract][Full Text] [Related]
37. Treatment planning and verification of proton therapy using spot scanning: initial experiences.
Lomax AJ; Böhringer T; Bolsi A; Coray D; Emert F; Goitein G; Jermann M; Lin S; Pedroni E; Rutz H; Stadelmann O; Timmermann B; Verwey J; Weber DC
Med Phys; 2004 Nov; 31(11):3150-7. PubMed ID: 15587667
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two methods for minimizing the effect of delayed charge on the dose delivered with a synchrotron based discrete spot scanning proton beam.
Whitaker TJ; Beltran C; Tryggestad E; Bues M; Kruse JJ; Remmes NB; Tasson A; Herman MG
Med Phys; 2014 Aug; 41(8):081703. PubMed ID: 25086513
[TBL] [Abstract][Full Text] [Related]
39. Shortening delivery times for intensity-modulated proton therapy by reducing the number of proton spots: an experimental verification.
van de Water S; Belosi MF; Albertini F; Winterhalter C; Weber DC; Lomax AJ
Phys Med Biol; 2020 May; 65(9):095008. PubMed ID: 32155594
[TBL] [Abstract][Full Text] [Related]
40. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.
Gordon JJ; Sayah N; Weiss E; Siebers JV
Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
